Dear Editor:
After reading the recent Breitbart article about the Most Favored Nation Policy, I’m reminded of one constant: Government control in markets never works. When European countries enacted similar policies in the 1980s, their invention rates plummeted as America overtook them by the early 1990s.
Why? The United States’ attractive policies toward innovation and investment led many European drug manufacturers to move across the Atlantic. By the turn of the century, Europe’s pharmaceutical research and development was growing at just around half the rate of the United States.
History shows that these sorts of price control policies harm self-sufficiency, cause job losses, and divest capital from a very important sector of the economy. China is already investing at triple our rate into pharmaceutical R&D in a play to dominate global drug production.
The CCP is all too willing to swoop in to take our place as the leader in global pharmaceutical trade. We must not allow the United States to be reliant on the Chinese Communist Party for life-saving treatments and cures.
Instead of importing failed foreign policies, we should follow President Trump’s lead in forcing Europe to pay their fair market prices for innovation they currently “freeload” from us. Protecting American innovation is a matter of national security.
Dot Key
Loading ...